Hirano T, Manabe T
First Department of Surgery, Faculty of Medicine, Kyoto University, Japan.
Acta Chir Belg. 1994 Mar-Apr;94(2):80-5.
Blockage of the rat pancreatico-biliary duct (PBDO) for 4 hours and secretin infusion (0.2 CU [Clinical Unit]/kg/hr) caused significant rises in portal serum amylase, cathepsin B levels, pancreatic water content, and pancreatic amylase content as well as lysosomal and mitochondrial fragility. Impaired pancreatic adenylate energy charge levels were also noted. These changes tended to continue for 12 hours after the release of PBDO and disappeared after 24 hours. All the changes induced by PBDO with secretin infusion were no longer observed at 48 hours. The administration of a new potent protease inhibitor, E-3123 at a dose of 5 mg/kg/hr during PBDO markedly attenuated all the parameters examined, exerting a significant protective effect on acinar cells in this model. These results indicate the important roles of subcellular organelle fragility and impaired pancreatic energy metabolism in the pathogenesis of pancreatic injuries induced by common channel obstruction with intraductal hypertension, and also indicate the possible usefulness of E-3123 in the treatment of acute pancreatitis such as gallstone pancreatitis.
将大鼠胰胆管阻塞(PBDO)4小时并输注促胰液素(0.2临床单位[CU]/千克/小时),会导致门静脉血清淀粉酶、组织蛋白酶B水平、胰腺含水量、胰腺淀粉酶含量以及溶酶体和线粒体脆性显著升高。还观察到胰腺腺苷酸能量荷水平受损。这些变化在解除PBDO后往往会持续12小时,并在24小时后消失。在48小时时,不再观察到PBDO联合促胰液素输注所诱导的所有变化。在PBDO期间以5毫克/千克/小时的剂量给予一种新的强效蛋白酶抑制剂E-3123,可显著减弱所有检测参数,对该模型中的腺泡细胞发挥显著的保护作用。这些结果表明,亚细胞器脆性和胰腺能量代谢受损在由共同通道梗阻伴导管内高压引起的胰腺损伤发病机制中起重要作用,也表明E-3123在治疗诸如胆石性胰腺炎等急性胰腺炎方面可能有用。